News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

AbSci Establishes New Collaboration with Sanofi

AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics
VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/

AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced a collaboration with Sanofi. Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization assay system, to two of Sanofi’s biotherapeutic molecules. AbSci’s proprietary technology platform is designed with the ability to rapidly achieve optimized, scalable, […]

January 18, 2019 |

Veana Therapeutics secures NIH funding for VIMO

Veana Therapeutics is pleased to announce a Phase I Small Business Innovation Research (SBIR) grant award from the NIH National Cancer Institute to conduct proof-of-concept pre-clinical studies of its lead product, VIMO (Veana Immune Modulator) in combination with immune checkpoint inhibitors in triple negative breast cancer. Learn more about Veana here.

November 12, 2018 |

DesignMedix Inc. wins PBJ’s Manufacturer of the Year (1-10 employees)

By Denise Szott – Contributing writer for Portland Business Journal

The Portland company developed a drug to cure malaria that is easy and cheap to manufacture

DesignMedix co-founder and Chief Scientific Officer David Peyton and a student carry out research at the DesignMedix Lab in the Portland State

 

Most of us have felt annoyed by the itchy red bump left by a mosquito dining on our blood. But in many parts of […]

Portland wearables maker gets $1.6M grant for physical therapy system

Elizabeth Hayes, Portland Business Journal

The system is a fraction of the cost of traditional rehab systems, such as instrumented treadmills, which run $80,000, according to APDM.

The system is a fraction of the cost of traditional rehab systems, such as instrumented treadmills, which run $80,000, according to APDM. STOCKSTUDIOX

A Portland wearables developer has landed $1.6 million as it helps older adults achieve independent movement.

The National Institute on Aging grant will help APDM […]

June 19, 2018 |

How a $600M jolt could get OHSU’s promising AIDS vaccine to market

Elizabeth Hayes, Portland Business Journal

ANDREW TOWNSEND OHSU VACCINE & GENE THERAPY INSTITUTE

When TomegaVax Inc. spun out from Oregon Health & Science University in 2011, it had the makings of a future bio-star.

The startup would commercialize the research from the OHSU Vaccine and Gene Therapy Institute, where Dr. Louis Picker and his colleagues were developing a vaccine to combat some of the greatest global health crises in the world — HIV/AIDS, malaria and tuberculosis. […]

June 15, 2018 |

Madison High graduate to attend Brown University as first-generation college student

Corlyn Vorhees, The Oregonian/Oregon Live

Madison High graduate Cynthia Bui will be attending Brown University in September.

Madison High graduate Cynthia Bui will be attending Brown University in September.

Cynthia Bui, who graduated from Madison High this week, started preparing for college when she was only 10.

She was the “really annoying know-it-all kid,” she said. “I genuinely enjoyed learning. I don’t think that’s changed. It’s gotten worse as I’ve gotten older.”

Bui learned three languages: Vietnamese by speaking it at […]

June 11, 2018 |

Eugene firm employs worms to transform drug research

Elizabeth Hayes, Portland Business Journal

The following story is part of this week’s package on the winners of the Portland Business Journal’s Small Business Innovation Awards.

Eugene-based NemaMetrix uses nematode worms to help scientists save money and time as they determine if a drug has therapeutic value or potentially dangerous side effects.

The startup’s ScreenChip System collects data after DNA from a human patient is injected into the worm, an excellent living proxy for a human.

“Honestly, I believe we’re […]

June 5, 2018 |

AbSci raises $12 million in Series C financing

Elizabeth Hayes, Portland Business Journal

AbSciwhich developed a technology to drive down the cost of insulin for treating diabetes, said Wednesday it has raised $12 million.

The oversubscribed Series C financing round will fuel commercialization of AbSci’s protein expression platform. SaluPro can accelerate biopharmaceutical discovery and development and reduce manufacturing costs.

The Vancouver, Washington-based company also announced that AGC Biologics President and CEO Dr. Gustavo Mahler will join AbSci’s board of directors. AGC, the parent company […]

Veana Therapeutics Announces Interim Results of the Phase I Trial for VIMO-001

Developing innovative immunotherapy products that effectively treat cancer patients and have minimal impact on their quality of life.

FOR IMMEDIATE PRESS RELEASE
April 5, 2018

Veana Therapeutics, Inc. is pleased to announce the interim results of the Phase I safety trial of its lead cancer immunotherapy drug asset, VIMO-001, in patients with advanced cancer. The Phase I clinical study is an “all comers” trial of patients with advanced and diverse cancer indications, including pancreatic, lung, prostate, renal, esophageal, colon, head and neck, and […]

April 6, 2018 |

Portland biotech community finally gets its wish: a new lab-office project

Elizabeth Hayes, Portland Business Journal

Summit Development Group to invest $12M in Central Eastside lab-office development

One of the biggest obstacles for biotech companies looking to expand in Portland is the city’s lack of suitable lab space.

That situation is about to change. A new 40,000-square-foot lab-office development, scheduled to get underway in April, is slated to open in the fall in Portland’s Central Eastside.

Summit Development Group bought a 100-year-old, three-story warehouse building on the corner of Southeast Eighth Avenue and Alder Street […]

March 1, 2018 |

Former Vice President Joe Biden on Monday said that under his new health care plan, people who like their insurance coverage won't be forced to give it up.Speaking at the AARP presidential forum [...]

Sen. Bernie Sanders (I-Vt.) on Monday attacked the pending closure of a Philadelphia hospital as an example of corporate greed taking priority over people's health.During a rally to save the 171- [...]

The FDA's March rejection of Sanofi and Lexicon Pharmaceuticals' Zynquista was just a preview of what would come for the SGLT class in Type 1 diabetes. The agency shot down AstraZeneca' [...]

WASHINGTON (AP) -- Medicare says it’s moving toward potentially covering acupuncture for chronic low back pain as an alternative to opioid painkillers that can become addictive. The agency announced i [...]

GE Healthcare has recalled two of its infant warmers--bedlike hospital devices designed to radiate heat and track the health of newborns--due to side panels and latches that may crack, break or open, [...]

GlaxoSmithKline laid out $5.1 billion last year for Tesaro and its key PARP inhibitor, Zejula, and with some new ovarian cancer data, it has another chance to prove the deal was worth it--and a shot a [...]

German pharma Boehringer Ingelheim is putting a few hundred million euros on the table to snap up Swiss cancer biotech Amal Therapeutics. [...]

Mr. Biden, who fought for the law as vice president, has criticized his progressive rivals who want to eliminate private health insurance. [...]